Skip to main content

Table 1 Patient characteristics (n = 118)

From: The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study

Characteristic

Value

Age

 

   Median

49

   Range

30–84

Menopausal Status

 

   Premenopausal

80 (68%)

   Postmenopausal

38 (32%)

Histologic Type

 

   Ductal Carcinoma

100 (84.7%)

   Lobular Carcinoma

6 (5.1%)

   Unclassified

12 (10.2%)

Clinical Primary Tumor

 

   T1

19 (16.1%)

   T2

19 (16.1%)

   T3

74 (62.7%)

   T4

6 (5.1%)

Chemotherapeutic Regimens*

 

   DEC

58 (49.2%)

   EFC

37 (31.4%)

   VFC

23 (19.5%)

  1. * D docetaxel, E epirubicin, C cyclophosphamide, F 5-Fluorouracil, V vinorelbine or vincristine